About this Journal Submit a Manuscript Table of Contents
Case Reports in Cardiology
Volume 2013 (2013), Article ID 246891, 3 pages
http://dx.doi.org/10.1155/2013/246891
Case Report

From Recurrent Syncope to Sudden Cardiac Death: Clinical Characteristics in a Chinese Patient Carrying a Plakophilin-2 Gene Mutation

1Peking University People’s Hospital, Beijing 100044, China
2China Meitan General Hospital, Beijing, China
3Lankenau Medical Center, Lankenau Institute for Medical Research, Wynnewood, PA, USA

Received 26 February 2013; Accepted 26 March 2013

Academic Editors: J. Peteiro, K. Roberts-Thomson, and M. Shirotani

Copyright © 2013 Wenling Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

We report a case of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) which illustrates the natural progression of disease in the absence of availability of an implanted cardiac defibrillator (ICD). Electrocardiograms and cardiac imaging show the progress of ARVC and these clinical milestones of disease are presented herein.

1. Background

ARVC is a largely inherited cardiomyopathy that affects mostly young otherwise healthy individuals and is associated with an increased risk of sudden death [1]. The morphological and arrhythmogenic substrate of ARVC predominantly affects the right ventricle (RV) [2] and is characterized by progressive myocardial atrophy with subsequent replacement by fatty and fibrous tissue [3]. Accordingly, the clinical process is also progressive [3, 4]. Here we review the entire progression of a young patient with ARVC from recurrent syncope to sudden cardiac death in the absence of ICD.

2. Case Presentation

An 18-year-old Chinese man was sent to the hospital after suffering syncope while playing basketball. After a 12-lead ECG revealed ventricular tachycardia (Figure 1) and a subsequent 24 hr Holter monitor and echocardiography revealed suggestive changes, ARVC was diagnosed according to the 1994 task force criteria [5], and the patient underwent VT ablation. After discharge, episodes of palpitation and syncope persisted during physical activity despite ablation. ICD therapy was strongly recommended to the family who ultimately declined for financial reasons. Bisolol daily and amiodarone were administered with eventual discontinuation of the amiodarone after one year. Episodes of palpitation and syncope disappeared with medical therapy, but the patient suffered sudden cardiac death (SCD) three years later while swimming at 22 years of age. 12-lead ECGs, 24 hr Holter monitoring, and echocardiography were recorded yearly during the 5-year followup. 12-lead ECG showed a markedly fractionated QRS and terminal S wave prolongation. The QRS duration was 130 ms with a large epsilon wave (Figure 2). Holter ECG revealed frequent multifocal PVCs (n3000–4000/24 h) and nonsustained VT with left bundle branch block morphology. His electrocardiogram and echocardiography worsened gradually from the onset of syncopal episodes to death. (Figure 3, Table 1). Holter ECG revealed frequent multifocal PVCs and nonsustained VT (Figure 4). Genetic testing affirmed the diagnosis through the identification of a PKP2 mutation (Figure 5).

tab1
Table 1: Right ventricle size on echocardiography.
246891.fig.001
Figure 1: Body surface 12-lead ECG documented in 2005.
fig2
Figure 2: T-wave progression on ECG and (a) T-wave inversion in leads V1, V2 in 2005; (b) T-wave inversion in leads V1~V3 in 2006; (c) T-wave inversion in leads V1~V4 in 2007 and 2008.
246891.fig.003
Figure 3: Body surface 12-lead ECG recording in 2 cm/mV and 50 mm/S. The arrows indicate epsilon waves, fractionated QRS complexes, and terminal S wave prolongation.
246891.fig.004
Figure 4: Holter ECG revealed frequent multifocal PVCs and nonsustained VT.
fig5
Figure 5: PKP2 mutation (above) versus wide type (bellow).

3. Discussion

The deterioration of parameters on ECG and ECHO indicates a poor prognosis. Such clearly illustrated progression from diagnosis to SCD on clinical testing allows for better visualization of disease progression and may heighten clinician suspicion of disease and recognition of an ominous course. The lifesaving therapy for ARVC is ICD placement and this case corroborates the diminishment of the prognosis in its absence.

Acknowledgments

This study was supported by Grant no. 81270166 of National Natural Science Foundation of China, Grant no. 2009-2031 of Capital Development Fund Beijing, China, and Grant no. 985-2-034-24 of 985 Project of China.

References

  1. D. Corrado, C. Basso, M. Schiavon, and G. Thiene, “Screening for hypertrophic cardiomyopathy in young athletes,” The New England Journal of Medicine, vol. 339, no. 6, pp. 364–369, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Kirchhof, L. Fabritz, M. Zwiener et al., “Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice,” Circulation, vol. 114, no. 17, pp. 1799–1806, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Corrado, C. Basso, G. Thiene et al., “Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study,” Journal of the American College of Cardiology, vol. 30, no. 6, pp. 1512–1520, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Pinamonti, G. Sinagra, A. Salvi et al., “Left ventricular involvement in right ventricular dysplasia,” The American Heart Journal, vol. 123, no. 3, pp. 711–724, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. W. J. McKenna, G. Thiene, A. Nava et al., “Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology,” The British Heart Journal, vol. 71, no. 3, pp. 215–218, 1994.